Klinische StudieKlinische Studie (Phase III)Randomisierte kontrollierte Studie
Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study
Biotherapy · 1993-01 · 6 (1) · 9-12
DOI: 10.1007/bf01877380 ↗At a glance
Klinische Studie in Biotherapy, 1993-01. Written by P Dufour and 7 co-authors. Institution: Service Onco-Hématologie, CHU de Hautepierre, Strasbourg, France. Cited 76 times so far (Crossref); 19 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Adjuvants, ImmunologicAdultAgedBreast NeoplasmsCombined Modality TherapyDitiocarbDouble-Blind MethodFemaleFollow-Up StudiesHumansMiddle AgedNeoplasm Recurrence, LocalRisk Factors
Substances
Adjuvants, ImmunologicDitiocarb
Authors and institutions
- Service Onco-Hématologie, CHU de Hautepierre, Strasbourg, France.
Cite
APA
Dufour, P., Lang, J. M., Giron, C., Duclos, B., Haehnel, P., Jaeck, D., Jung, J. M., & Oberling, F. (1993). Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy, 6(1), 9-12. https://doi.org/10.1007/bf01877380
Vancouver
Dufour P, Lang JM, Giron C, Duclos B, Haehnel P, Jaeck D, et al. Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy. 1993;6(1):9-12. doi:10.1007/bf01877380
BibTeX
@article{Dufour1993,
author = {Dufour, P and Lang, J M and Giron, C and Duclos, B and Haehnel, P and Jaeck, D and Jung, J M and Oberling, F},
title = {Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study},
journal = {Biotherapy},
year = {1993},
volume = {6},
number = {1},
pages = {9--12},
doi = {10.1007/bf01877380}
}
EUVIMED